Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol

Nina Toft,Henrik Birgens,Jonas Abrahamsson,Per Bernell,Laimonas Griskevicius,Helene Hallböök,Mats Heyman,Mette Holm,Erik Hulegårdh,Tobias Wirenfeldt Klausen,Hanne Vibeke Marquart,Olafur G. Jonsson,Ove Juul Nielsen,Petter Quist-Paulsen,Mervi Taskinen,Goda Vaitkevičienė,Kim Vettenranta,Ann Åsberg,Kjeld Schmiegelow

Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol

2013

Nina Toft
Henrik Birgens
Jonas Abrahamsson
Per Bernell
Laimonas Griskevicius
Helene Hallböök
Mats Heyman
Mette Holm
Erik Hulegårdh
Tobias Wirenfeldt Klausen
Hanne Vibeke Marquart
Olafur G. Jonsson
Ove Juul Nielsen
Petter Quist-Paulsen
Mervi Taskinen
Goda Vaitkevičienė
Kim Vettenranta
Ann Åsberg
Kjeld Schmiegelow

BACKGROUND: The prognosis of acute lymphoblastic leukemia is poorer in adults than in children. Studies have indicated that young adults benefit from pediatric treatment, although no upper age limi ...

Keywords:

Diabetes mellitus
Minimal residual disease
Young adult
Pediatrics
Lymphoblastic Leukemia
Medicine
Prednisone
Induction chemotherapy
Vincristine
Hematopoietic stem cell transplantation
Methotrexate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

102

Citations